Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Hepatocellular
×
regorafenib
×
Clear all
Filters
3
NCT04777851
2026-03-09
REPLACE
Translational Research in Oncology
Phase 3
Terminated
45 enrolled
NCT01774344
2020-08-20
RESORCE
Bayer
Phase 3
Completed
573 enrolled
23 charts